Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-25 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −1,500 269,000
2021-06-24 Mills Kenneth T. President and CEO Option exercise +4,500 $3.76 $17K 285,484
2021-06-24 Mills Kenneth T. President and CEO Sale −4,500 $40.02 $180K 280,984
2021-06-24 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −4,500 270,500
2021-06-04 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-04 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-04 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-04 Glucksmann Alexandra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-04 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-04 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-04 Abdun-Nabi Daniel Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-02-25 Mills Kenneth T. President and CEO Option exercise +1,500 $0.85 $1K 282,484
2021-02-25 Mills Kenneth T. President and CEO Sale −1,500 $40.77 $61K 280,984
2021-02-25 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −1,500 39,670
2021-02-12 Christmas Patrick J. Chief Legal Officer Option exercise +4,701 $12.10 $57K 21,073
2021-02-12 Christmas Patrick J. Chief Legal Officer Sale −4,701 $49.08 $231K 16,372
2021-02-12 Christmas Patrick J. Chief Legal Officer Option exercise · Employee Stock Option (Right to Buy) −4,701 6,430
2021-02-08 Christmas Patrick J. Chief Legal Officer Option exercise +1,300 $12.10 $16K 17,672
2021-02-08 Christmas Patrick J. Chief Legal Officer Sale −1,300 $49.11 $64K 16,372
2021-02-08 Christmas Patrick J. Chief Legal Officer Option exercise · Employee Stock Option (Right to Buy) −1,300 11,131

Page 17 of 25 · 494 trades